stockrowWarby Parker Inc.
WRBY Healthcare Medical Instruments & Supplies
Warby Parker Inc.’s revenue for fiscal 2025 (year ended December 2025) was $871.9 million, up 13.0% from fiscal 2024.
- Revenue
- +10.4%
- EPS
- −20.0%
- Free cash flow
- −30.3%
Quarter to September 2026, against a year earlier
Follow WRBY
Alert me
Warby Parker Inc. (WRBY) Revenue growth
Warby Parker Inc.'s revenue growth over the twelve months to 30 September 2026 was 9.89%, down 3.2 percentage points from fiscal 2025 (13.0%). Over the past ten years it has ranged from −5.91% (fiscal 2019) to 37.4% (fiscal 2021); the current reading is higher than 71% of that period. That is above the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 13.0% | (2.12) |
| FY2024 | 15.2% | 3.18 |
| FY2023 | 12.0% | 1.38 |
| FY2022 | 10.6% | (26.76) |
| FY2021 | 37.4% | 31.08 |
| FY2020 | 6.28% | 12.19 |
| FY2019 | −5.91% | — |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 10.4% | 0.59 |
| Jun 2026 | 9.81% | 1.47 |
| Mar 2026 | 8.34% | (2.85) |
| Dec 2025 | 11.2% | (4.00) |
| 21 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| KMTS Kestra Medical Technologies, Ltd. compare | 60.7% |
| ATRC AtriCure, Inc. compare | 13.8% |
| LMAT LeMaitre Vascular, Inc. compare | 11.8% |
| STVN Stevanato Group S.p.A. compare | 11.6% |
| WRBY Warby Parker Inc. | 9.89% |
| AZTA Azenta, Inc. compare | 4.80% |
| XRAY DENTSPLY SIRONA Inc. compare | −1.35% |
| ICUI ICU Medical, Inc. compare | −5.92% |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on WRBY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement